Strengthening the EU vaccine ecosystem: managing the digital transformation
Digital transformation is taking place rapidly in all sectors across Europe, but the challenges presented by wide-scale digitalisation have been particularly apparent in health systems.
4th scientific session 'Viral Evolution and Evasion'
Chair Prof Albert Osterhaus will be joined by Prof Derek J. Smith and Dr Sylvie C. Briand to discuss mechanisms of viral evolution and evasion and how viral evolution is predicted and used to inform vaccine and therapeutics development.
Severe asthma patient conference
Virtual patient conference focused on living well with severe asthma, latest advances in treatment and new research
Coalition for Vaccination conference
European and national vaccination policies and the results of the EU co-funded IMMUNION project will be discussed by healthcare professionals, policymakers, civil society, researchers, and the general public.
International Universal Health Coverage Day
On 12 December 2012, the United Nations General Assembly endorsed a resolution urging countries to accelerate progress toward universal health coverage (UHC).
One Year of HERA
The European Health Emergency Preparedness and Response Authority (HERA), a key pillar of the European Health Union, celebrates its one year anniversary.
Behind the scenes in the race against COVID
Be Curious, a new event series, to get the inside track on global challenges from some of today’s most influential scientists.
World Diabetes Congress 2022
The IDF World Diabetes Congress 2022 in Lisbon provides the ideal forum for the global diabetes community to continue to make the case for the level of attention, recognition and resources that diabetes deserves.
International Congress for Infectious Diseases Congress 2022
The International Society for Infectious Diseases (ISID) will hold its next in-person and virtual International Congress on Infectious Diseases November 17–20, 2022 in Kuala Lumpur, Malaysia.
Vaccines & special-risk groups: Diabetes
FIP (International Pharmaceutical Federation) new series “Vaccines & special-risk groups” will discuss and highlight the risks that particular population groups are exposed to with regards to vaccine-preventable diseases.
